Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo

Peptide encyclopedia · Metabolic & incretin research

Tirzepatide comparison

Incretin dual-agonist peptide · Full compound profile

Also see the expanded Tirzepatide compound database page with filters, related articles, and catalog links.

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.

Tirzepatide is a Incretin dual-agonist peptide. It is not Semaglutide or Retatrutide. This page separates those catalogue records. It is not stacking advice and not a protocol.

Tirzepatide
Incretin dual-agonist peptide; CAS 2023788-19-2
Not the same record as
Semaglutide, Retatrutide
What decides the vial
Name, nominal fill, and lot number

Tirzepatide on its own record

Tirzepatide is a dual GIP/GLP-1 receptor agonist peptide characterised extensively in metabolic research literature. Pharmaceutical finished products exist under specific indications in some markets. VaultLabs supplies Tirzepatide as a lyophilised reference material for in vitro laboratory research only — not as a medicine.

Chemical name: Tirzepatide.

Common synonyms: LY3298176, dual GIP/GLP-1 receptor agonist peptide.

CAS number: 2023788-19-2 (registry entry).

Molecular formula: C225H348N48O68.

Tirzepatide 30mg is the 30 mg lyophilized unit, listed at AED 599 before VAT. The product record stores that sealed unit at 2–8 °C · protect from light.

How Tirzepatide differs from the linked records

Tirzepatide versus Semaglutide. Semaglutide is a selective GLP-1 agonist — dual vs single incretin profiles should not be conflated in documentation. Tirzepatide is listed with CAS 2023788-19-2. Semaglutide is listed with CAS 910463-68-2. A certificate for Semaglutide does not qualify a Tirzepatide vial, and the reverse is also true. Read Semaglutide on its own monograph rather than inferring it from this page.

Tirzepatide versus Retatrutide. Retatrutide engages GLP-1, GIP and glucagon pathways — a triple-agonist framework distinct from tirzepatide. Tirzepatide is listed with CAS 2023788-19-2. Retatrutide is listed with CAS 2381089-83-2. A certificate for Retatrutide does not qualify a Tirzepatide vial, and the reverse is also true. Read Retatrutide on its own monograph rather than inferring it from this page.

Certificates do not cross over

Lot VL-TIRZ-20260801 is the catalogue certificate for Tirzepatide 30mg. Read it on Tirzepatide 30mg certificate and match the vial in batch verification. A certificate for a different strength, or for a blend that merely contains the same name, does not release this unit.

If a purchase order says Tirzepatide, a vial of a related compound does not satisfy it. If the order names a strength, a different strength of Tirzepatide does not satisfy it either.

What this comparison refuses to do

It does not rank Tirzepatide against another material, recommend a combination, or translate a paper into a dose. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Prices and the literature notes are on the Tirzepatide research summary. Sealed-unit handling is the Tirzepatide storage guide. The Tirzepatide compound monograph remains the long record.

VaultLabs dispatches Tirzepatide from Dubai. Orders leave fulfillment within 24 hours, 7 days a week. Standard delivery is AED 35 to every emirate, and delivery is free when the post-discount merchandise subtotal is AED 500 or more. Checkout shows the fee for the address entered. All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use. VaultLabs does not provide dosage, administration, study-design, or medical guidance.

Questions this page answers

Is Tirzepatide the same material as Semaglutide?

No. Tirzepatide is a Incretin dual-agonist peptide. CAS 2023788-19-2. Semaglutide is a separate catalogue record (CAS 910463-68-2). Use the monograph for each one.

Can a blend certificate stand in for Tirzepatide?

No. A blend that contains Tirzepatide, or a similarly named component, has its own lot. That document does not release a single-sequence Tirzepatide vial, and a Tirzepatide certificate does not release the blend.

Related compounds

Research tools

Catalog products

Next recommended reading

All VaultLabs products are supplied strictly for laboratory and research use only. They are not intended for human consumption, medical use, personal use, or diagnostic use.